When Steven Galson, then-acting director of the Center for Drug Evaluation and Research, announced the rejection, he said the decision was his own, had been recently made and was based on scientific concerns. The GAO report, however, indicates the decision was solidified months earlier and that other top officials were involved in the decision.
...The draft GAO report indicates that Galson voiced concerns in FDA meetings about how easier availability of Plan B would effect sexual behavior by girls.
Translation: We're doing this to keep girls from becoming sluts despite our overwhelmingly successful abstinence education. Our morals trump yours.
No comments:
Post a Comment